Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Azacitidine with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01155583Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jun 2010
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in multiple myeloma (MM), sponsored by Case Comprehensive Cancer Center. Started Jun 2010; status: completed.
02
Drugs
azacitidine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01155583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155583.